Indirect costs associated with deaths from the Ebola virus disease in West Africa by Joses Muthuri Kirigia et al.
RESEARCH ARTICLE Open Access
Indirect costs associated with deaths from
the Ebola virus disease in West Africa
Joses Muthuri Kirigia1*, Felix Masiye2, Doris Gatwiri Kirigia3 and Patricia Akweongo4
Abstract
Background: By 28 June 2015, there were a total of 11,234 deaths from the Ebola virus disease (EVD) in five West
African countries (Guinea, Liberia, Mali, Nigeria and Sierra Leone). The objective of this study was to estimate the
future productivity losses associated with EVD deaths in these West African countries, in order to encourage increased
investments in national health systems.
Methods: A cost-of-illness method was employed to calculate future non-health (NH) gross domestic product (GDP)
(NHGDP) losses associated with EVD deaths. The future non-health GDP loss (NHGDPLoss) was discounted at 3 %.
Separate analyses were done for three different age groups (< =14 years, 15–44 years and = >45 years) for the five
countries (Guinea, Liberia, Mali, Nigeria, and Sierra Leone) affected by EVD. We also conducted a one-way sensitivity
analysis at 5 and 10 % discount rates to gauge their impacts on expected NHGDPLoss.
Results: The discounted value of future NHGDPLoss due to the 11,234 deaths associated with EVD was estimated to
be Int$ (international dollars) 155,663,244. About 27.86 % of the loss would be borne by Guinea, 34.84 % by Liberia,
0.10 % by Mali, 0.24 % by Nigeria and 36.96 % by Sierra Leone. About 27.27 % of the loss is attributed to those aged
under 14 years, 66.27 % to those aged 15–44 years and 6.46 % to those aged over 45 years. The average NHGDPLoss
per EVD death was estimated to be Int$ 17,473 for Guinea, Int$ 11,283 for Liberia, Int$ 25,126 for Mali, Int$ 47,364 for
Nigeria and Int$ 14,633 for Sierra Leone.
Conclusion: In spite of alluded limitations, the estimates of human and economic losses reported in this
paper, in addition to those projected by the World Bank, show that EVD imposes a significant economic
burden on the affected West African countries. That heavy burden, coupled with human rights and global
security concerns, underscores the urgent need for increased domestic and external investments to enable
Guinea, Liberia and Sierra Leone (and other vulnerable African countries) to develop resilient health systems,
including core capacities to detect, assess, notify, verify and report events, and to respond to public health
risks and emergencies.
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Background
The estimated population of the six West African coun-
tries (Guinea, Liberia, Mali, Nigeria, Senegal and Sierra
Leone) affected by the Ebola virus disease (EVD) was
225,181,000, representing 24.3 % of the entire African
Region population. The annual population growth rate
varied from 2.4 % in Guinea to 3.2 % in Liberia between
2003 to 2013. Between 36 and 49 % of the population
lives in urban areas – a sizeable proportion resides in
overcrowded and unsanitary informal settlements. The
literacy rate among adults aged 15 years and above var-
ied from 33 % in Mali to 61 % in Liberia. The gross na-
tional income per capita (GDPPC) varied between Int$
(international dollars) 790 in Liberia to Int$ 5360 in
Nigeria. The percentage of population living below Int$* Correspondence: kirigiaj@who.int1Health Systems and Services Cluster, World Health Organization, Regional
Office for Africa, Brazzaville, Congo
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1 per day varied from 34.1 % in Senegal to 83.8 % in
Liberia [1].
Physicians, nursing and midwifery personnel, dentistry
personnel, pharmaceutical personnel and psychiatrists
are the key cadres of the health system. Except for in
Nigeria – where the densities of physicians and nursing
and midwifery personnel are higher than the African Re-
gion averages – the workforce densities were much
lower than both the regional and global averages in the
other five West African countries even before the EVD
outbreak. The density of hospitals is also lower in EVD-
affected countries compared to the regional and global
averages. In addition, only Nigeria was spending 18 % of
the total government budget on the health sector. This
implies that even before the EVD outbreak occurred the
other five countries did not meet the Abuja target of al-
locating at least 15 % of the national budget to the
health sector. The per capita total expenditure on health
(PCTEH), which was between Int$ 56 and Int$ 184 in
EVD-affected countries, was lower than the African Region
(Int$ 208) and global (Int$ 1173) averages [1]. Partially, as
a result of years of civil conflict and underinvestment in
health systems, the health services coverage even prior to
the EVD outbreak was sub-optimal at best and disease sur-
veillance capacities were weak especially in Guinea, Liberia
and Sierra Leone [2].
Due to relatively weak national health systems, the
EVD outbreak that was first reported in March 2014 in
Guinea rapidly spread to other West African countries.
As of 28 June 2015, a total of 27,543 cases of EVD were
reported, of which 13.539 % were in Guinea, 38.725 % in
Liberia, 0.029 % in Mali, 0.0726 % in Nigeria, 0.0034 %
in Senegal and 47.631 % in Sierra Leone. The cumulative
number of EVD-related deaths was 11,234, with 22.094 %
of these in Guinea, 42.781 % in Liberia, 0.054 % in Mali,
0.071 % in Nigeria and 35 % in Sierra Leone [3].
According to the World Bank, apart from the loss of hu-
man lives and suffering, the EVD epidemic has also had a
significant impact on the economies of the affected coun-
tries in terms of ‘…forgone output; higher fiscal deficits;
rising prices; lower real household incomes and greater
poverty’ [4]. The World Bank projected that the combined
gross domestic product (GDP) loss for Guinea, Liberia and
Sierra Leone, the three countries most severely affected by
EVD, would be US$ 359 million in the short term (2014),
US$ 129 million in a low Ebola prevalence scenario in the
medium term (2015), and US$ 815 million in a high Ebola
prevalence scenario in the medium term (2015) [4]. How-
ever, the World Bank analysis did not take into account
the long-term impacts of mortality, failure to treat other
health conditions as patients avoided health facilities in
fear of contracting EVD, weakened healthcare supply cap-
acity due to death of over 500 health workers, school clo-
sures and dropouts, and other shocks to livelihoods [4].
This paper attempts to answer the question: What is the
impact of deaths associated with EVD on future non-
health GDP (NHGDP) (i.e., GDP minus the total health
expenditure) in the West African Region? The specific
objective was to estimate future productivity losses of
deaths associated with EVD in the West African Region
in an effort to complement the World Bank projections
and advocate for increased investments in health sys-
tems (including disease surveillance).
Methods
Conceptual framework
Fear, panic, morbidity and deaths associated with EVD
had a negative impact on the economies of affected
countries, especially Guinea, Liberia and Sierra Leone.
This included the effects on real economic activities
such as production, consumption, saving, investment,
imports and exports. Changes in real economic activ-
ities, for example, changes in business cycles or in eco-
nomic growth due to EVD would consequently affect
future GDP. The GDP is the sum of households’ con-
sumption expenditures (C), investment (I), government
expenditures (G) and net exports (X), i.e., exports minus
imports [5].
The category of ‘C’ comprises expenditures on consum-
able goods and services, such as health, education, food,
clothing, transport, books, stationery, cooking utensils, en-
tertainment, toiletries, newspapers, bicycles and motorcy-
cles, private vehicles, etc. ‘C’ depends on real disposable
income (i.e., income after taxation), wealth, the average
price level, expectations, habits, demographic factors, etc.
The category ‘I’ denotes the purchase of capital goods
or real assets on which a return is expected from the
sales of production, e.g., buildings, public vehicles, tractors
and machinery. ‘I’ depends on interest rates, expectations,
business confidence and regulations. Usually money for
investment comes from saved disposable income.
The category ‘G’ denotes purchase of goods and services
by the government, e.g., roads, security forces (police and
armed forces), medicines and supplies for public health fa-
cilities, stationary and salaries of civil servants. ‘G’ depends
on total tax revenues (which depend on incomes) and
borrowing.
The category ‘X’ refers to net exports, i.e., exports
minus imports. Exports denote spending by foreigners
on goods (e.g., minerals, agricultural products) and ser-
vices (e.g., tourism and expatriate technical services)
produced in EVD affected countries. The factors that de-
termine exports include prices of locally produced goods
relative to prices of imported goods (terms of trade), the
exchange rate between local and foreign currencies, total
income in foreign countries, trade policy in foreign
countries (import taxes, tariffs, quotas, etc.) and trade
sanctions or boycotts or bans. For example, some foreign
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countries banned exports of goods and services from
EVD affected countries.
Imports refer to purchase of foreign consumer (e.g.,
clothes, petroleum and pharmaceuticals) and capital
goods (e.g., Machinery, equipment) by citizens of EVD af-
fected countries households, business enterprises, govern-
ments and parastatal institutions. Import expenditures are
dependent on total income in EVD affected countries,
prices of imported goods relative to the prices of locally
produced goods, exchange rate, trade policy (import taxes,
tariffs, quotas, etc.) and trade sanctions or boycotts or
bans. For instance, some countries banned their airlines
from flying to EVD affected countries and recalled non-
medical expatriates hitherto working in those countries.
In EVD-affected countries, large numbers of people
living off the agricultural sector fell seriously ill, some
died and others fled their farms due to fear of con-
tracting EVD. This in turn lead to a reduction in output;
some mining, manufacturing and service industries closed
down, and the volume of exports also diminished with the
ban of commodities from EVD-affected countries. The de-
crease in economic activity and the ensuing increase in
unemployment led to a decrease in disposable income
and, hence, consumption, tax revenues, savings and in-
vestments [4].
This study employs a cost-of-illness method to esti-
mate the impact of deaths associated with EVD on non-
health components of future GDP [6, 7]. The ‘quantity
of interest’ is the impact of deaths associated with EVD
on the non-health components of GDP, because the use
of health services or goods does not generate utility or
welfare per se [8]. According to the economic theory of
health production, consumers do not derive satisfaction
from the consumption of medical services per se. For
example, injections and radiology and surgical proce-
dures are painful and some medicines are tasteless or
have bitter taste. Thus, people in need use them not be-
cause of the satisfaction they provide but due to expected
satisfaction from restored or improved health. The World
Health Organization (WHO) [6] and Chisholm et al. [7]
stipulate that the quantity of interest cannot be GDP, as
medical care and health expenses actually form part of
GDP. Instead, the impact of disease or injury on the non-
health components of GDP is a more appropriate meas-
urement of the quantity of interest.
Calculations of the non-health GDP loss for each age
group
The non-health GDP loss (NHGDPLoss) for each of the
five EVD-affected countries was estimated separately for
three different age groups: 0–14 years, 15–44 years and
45 years and above. The WHO EVD situation document
reports numbers of cases and deaths classified in these
same age categories [3].
The NHGDPLoss due to deaths associated with
EVD for the 0–14 years age group in jth country
(NHGDPLoss0 − 14) is the product of the total number
of discounted years of life lost (DYLL) above the
minimum employment age lost, the per capita non-
health GDP (NHGDPPC) in purchasing power parity
(PPP) (NHGDPPCInt$) and the total number of deaths
associated with EVD (TEVDD) in that age group
(TEVDD0 − 14). The number of years of life lost (YLL)
for this age group was calculated by subtracting the
average age at death (AAD) (AAD0 − 14) from each
country’s life expectancy at birth (LE). AAD0 − 14 is
equal to 0 plus 14 years divided by 2, (0 + 14/2) = 7.
A simple average was used, as the WHO EVD situ-
ation report, dated 1 July 2015, didn’t show the distri-
bution of deaths by age. Because the legal minimum
age of employment is 15 years, as according to article
2 of the International Labour Organization conven-
tion [9], the number of the future productive years of
life lost (PYLL) equals each country’s average LE
minus 14 years. For example, the PYLL among 0–14
year olds in Guinea is 44 years, i.e., LE of 58 years
minus the sum of AAD45 − LE (i.e., seven years) and
years remaining to attain the minimum age of em-
ployment (i.e., seven years).
PYLL0−14 ¼ 58− 0þ 14=2ð Þ þ 7ð Þ ¼ 44years:½

































The NHGDPLoss due to deaths associated with
EVD for the 15–44 years age group in jth country
(NHGDPLoss15 − 44) is the product of the total number
of DYLL, NHGDPPC in PPP (NHGDPPCInt$) and the
TEVDD in that age group (TEVDD15 − 44). The num-
ber of YLL for this age group was calculated by sub-
tracting the AAD (AAD15 − 44) from each country’s
average LE. AAD15 − 44 is equal to 15 plus 44 years di-
vided by 2, (15 + 44/2). The formula for the 15–45
years age group is as follows:
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Similarly, the NHGDPLoss due to deaths associated
with EVD for those aged between 45 years and the age
of LE in jth country (NHGDPLoss45 − LE) is the product of
the total number of DYLL, NHGDPPC in PPP
(NHGDPPCInt$) and TEVDD in that age group
(TEVDD45 − LE). The number of YLL for this age group
was calculated by subtracting the AAD (AAD45 − LE)
from each country’s average LE. AAD45 − LE is equal to
45 plus LE divided by 2, e.g., as LE of Guinea was
58 years, AAD45 − LE = (45 + 58/2) = 51.5. The formula
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In all three equations, 1/(1 + r)t is the discount fac-
tor, r is the rate of discount of future losses, t is the
first year of life lost and n is the final year of the
total number of YLL per death associated with EVD.
Thus, NHGDPPCInt$ is obtained by subtracting the
per capita total health expenditure (PCTHE) from the
per capita GDP (Int$ GDPPC) for each EVD-affected
country. We used 2013 as the year on the basis of
which losses potentially occurring in future years were dis-
counted. The size of the discount factor decreases as one
moves from the base year into future years, and, as a result
losses in successive years are given a lower value relative
to the same losses in the first year. This is due to existence
of time preference – meaning individually and as a society
we prefer to have dollars or resources now as opposed to
later because we can benefit from them in the interim.
Therefore, as Drummond et al. further explains, future
dollar cost and benefit streams are reduced or ‘discounted’
to reflect the fact that dollars spent or saved in the future
should not weigh as heavily in programme decisions as
dollars spent or saved today [10]. The weight (discount
factor) applied to the GDP losses of different years then
depends not just on the discount rate, r, but also on the
number of years, t, over which the discounting has been
applied. When discounting is applied so that all GDP
losses are re-valued relative to year 0 (i.e., 2013 in this
study), the re-valued values are called present values [10].
Calculation of losses in the total non-health GDP
The example below showing the calculation of loss asso-
ciated with deaths from EVD in non-health GDP uses
actual information on Guinea:
(a) TEVDD as of 28 June 2015 = 2482
(b) LE = 58 years
(c) Proportion of total deaths that occurred in the 0–
14 years age group = 0.16
(d) Proportion of total deaths that occurred in the 15–44
years age group = 0.58
(e) Proportion of total deaths that occurred in the 45–58
years age group = 0.26
(f ) TEVDD in the 0–14 years age group as of 28 June
2015 (TEVDD0 − 14) = (a) × (c) = 392
(g) TEVDD in the 15–44 years age group as of 28 June
2015 (TEVDD15 − 44) = (a) × (d) = 1438
(h) TEVDD in the 45–58 years age group as of 28 June
2015 (TEVDD45 − 58) = (a) × (e) = 652
(i) AAD in the 0–14 years age group (AAD0 − 14) =
(0 + 14/2) = 7 years
(j) Years remaining to attain minimum employment
age = 14 – 7 = 7 years
(k) Undiscounted PYLL in the 0–14 years age group =
LE – (AAD0 − 14 +7) = 58 – (7 + 7) = 44 years
(l) Discounted PYLL in the 0–14 years age group =
24.25427392 years
(m)AAD in the 15–44 years age group (AAD15 − 44) =
(15 + 44/2) = 29.5 years
(n) Undiscounted PYLL in the 15–44 years age group
= LE – (AAD15 − 44) = 58 – 29.5 = 28.5 years
(o) Discounted PYLL in the 15–44 years age group =
19.18845459
(p) AAD in the 45–58 years age group (AAD45 − 58) =
(45 + 58/2) = 51.5 years
(q) Undiscounted PYLL in the 45–58 years age group
= LE – (AAD15 − 44) = 58 – 51.5 = 6.5 years
(r) Discounted PYLL in the 45–58 years age group =
6.230282955
(s) Int$ GDPPC = Int$ 1129.352
(t) PCTHE = Int$ 75.836
Kirigia et al. Infectious Diseases of Poverty  (2015) 4:45 Page 4 of 10
(u) NHGDPPC =GDPPC (Int$ 1129.352) − PCTHE
(Int$ 75.836) = Int$ 1053.516
(v)r = 3 %
(w) (NHGDPLoss0 − 14) = (L)x(u)x(f ) = 24.25427392 ×
1053.516 × 392 = Int$ 10,016,488.13
(x) (NHGDPLoss15 − 44) = (o)x(u)x(g) = 19.18845459 ×
1053.516 × 1438 = Int$ 29,069,665
(y)(NHGDPLoss45 − 58) = (r)x(u)x(h) = 6.230282955 ×
1053.516 × 652 = Int$ 4,279,534.21
(z)Total NHGDPLoss in Guinea = (w) + (x) + (y) = Int$
10,016,488 + Int$ 29,069,665 + Int$ 4,279,534 = Int$
43,365,687
The above formulas were calculated using Excel to
avoid errors. The NHGDPLoss for the other four West
African countries were estimated the same way.
Data sources and analysis
The data on LE, total child deaths, the GDPPC in
PPP and PCTHE for each of the six EVD-affected
West African countries were obtained from the
World Health Statistics 2015 [1].
Ethical clearance
This study was entirely based on analysis of published
secondary data available in the public domain. There-
fore, given that no human subjects were involved, the
study did not require ethical clearance from the Ethics
Review Committee of the WHO Regional Office for
Africa.
Results
The 11,234 EVD deaths that occurred in the African Re-
gion as of 28 June 2015 could potentially decrease future
total NHGDP of the affected countries by Int$ 155,663,244
(see Fig. 1). Approximately 36.96 % of the loss would be
borne by Sierra Leone, 34.84 % by Liberia, 27.86 % by
Guinea, 0.24 % by Nigeria and 0.10 % by Mali (see Fig. 2).
In terms of age, 27.27 % of the total NHGDPLoss was
attributed to deaths that occurred in those aged 14 years
or below, 66.27 % in those aged 15–44 years and 6.46 %
in those aged over 45 years (see Table 1).
The average NHGDP lost per death associated with
EVD was Int$ 17,473 for Guinea, Int$ 11,283 for Liberia,
Int$ 25,126 for Mali, Int$ 47,364 for Nigeria and Int$
14,633 for Sierra Leone. The average NHGDPLoss per
death associated with EVD in Nigeria was more than
three times the overall average loss of Int$ 13,856 (see
Table 2). These values were obtained by dividing a coun-
try’s total productivity loss by its TEVDD. The overall
average NHGDPLoss per death of Int$ 13,856 was ob-
tained by dividing all countries total productivity loss
(Int$ 155,663,244) by total number of EVD deaths
(11,234).
The expected PYLL per death is dependent on the
GDPPC. For instance, even though there were only
eight deaths associated with EVD in Nigeria (a lower
middle-income country), the NHGDPLoss per death as-
sociated with EVD was relatively high at Int$ 47,364.
Low-income countries such as Guinea, Liberia and Sierra
Leone with relatively high TEVDD of 2482, 4806 and 3932
have comparatively low productivity losses per death asso-
ciated with EVD of Int$ 17,473, Int$ 11,283 and Int$
14,633, respectively.
Average GDP losses
The average NHGDPLoss per person for the five coun-
tries is shown in Table 3. The average NHGDPLoss per
person for each country was estimated by dividing the
country’s total NHGDPLoss by its population. Under-
standably, the average NHGDPLoss per person in
Liberia and Sierra Leone is around three times that of
Guinea due to the significantly smaller populations in
Liberia and Sierra Leone. The NHGDPLoss per person
in Mali and Nigeria was at least 300 % lower than those
in Guinea, Liberia and Sierra Leone due the small num-
ber of deaths associated with EVD in Mali and Nigeria.
The NHGDPLoss varied from a minimum of Int$ 0.0022
per person in Nigeria to a maximum of Int$ 12.63 per per-
son in Liberia. Therefore, the average NHGDPLoss per
person is largely dependent on both the population size
and the number of deaths associated with EVD.
Sensitivity analysis
We applied a discount rate of 3 % to convert future
loses into their present values, as this rate had been
previously used in various arenas, including the WHO
health systems’ performance assessment [11], global
burden of disease studies [12], the Institute for Health
Metrics and Evaluation’s global burden of disease stud-
ies [13] and health interventions economic evaluation
studies in Africa [14]. However, to test the effect of the
discount rate on the total expected NHGDPLoss esti-
mate, a one-way sensitivity analysis was conducted at
5 % and 10 % discount rates. The 5 % discount rate re-
duced the total expected NHGDPLoss by Int$ 31.5 mil-
lion (22 %) and the average non-health cost per death
associated with EVD by Int$ 2802. The 10 % discount
rate reduced the total NHGDPLoss by Int$ 75.8 million
(48.7 %) and the average non-health cost per death as-
sociated with EVD by Int$ 6745. This indicates that the
range of the NHGDPLoss is partially dependent on the
discount rate used.
Discussion
It is expected that the five West African countries will
sustain a loss of about 0.03 % of their non-health GDP
due to future YYL, as a result of 11,234 EVD-related
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deaths. Majority (66.27 %) of the total NHGDPLoss was
attributed to deaths that occurred in those aged 15–44
years, i.e., the most productive bracket. And about a
quarter of the NHGDPLoss was attributed to deaths that
occurred in those aged 14 years or below, which may
imply intergenerational economic effects of the EVD
public health emergency.
The reader will recall that the World Bank projected
that the combined GDP loss for Guinea, Liberia and
Sierra Leone, the three countries most severely affected
by EVD, would be US$ 359 million in the short term
(2014), US$ 129 million in a low Ebola prevalence sce-
nario in the medium term (2015), and US$ 815 million
in a high Ebola prevalence scenario in the medium term
(2015) [4]. Our study estimates that in addition to these
short-term and medium term losses, the three countries
are expected incur a loss of approximately Int$ 155.7
million due to premature EVD-related mortality. This
loss is significant when one takes into account that nearly
40.9, 83.8 and 56.6 % of the populations in Guinea, Liberia
and Sierra Leone live below the international poverty line
of Int$1 per day [1].
In order to prevent the recurrence of the human and
economic losses reported in this paper, in addition to
those projected by the World Bank, there is an urgent
need for increased investments in national health sys-
tems [15–18] – as well as in systems for addressing
other determinants of health (such as education, shelter,
clean sanitation and water) – as the three countries most
severely affected by EVD (Guinea, Liberia and Sierra
Leone) aim to meet their post-2015 Sustainable Devel-
opment Goals.
Fig. 1 Discounted NHGDPLoss from deaths associated with EVD in the five West African countries (in Int$, PPP)
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In addition, the EVD outbreak in West Africa under-
scores the urgency of mobilizing domestic (public and
private sector) and external resources to support full
implementation of the International Health Regulations
(2005) (IHR), which obliges for all States Parties to es-
tablish at local, intermediate and national public health
response levels core capacities to detect, assess, notify,
verify and report events, and to respond to public
health risks and emergencies [19]. The WHO Review
Committee on IHR partially attributed catastrophic ef-
fects of the EVD outbreak in the severely affected West
African to the lack of core IHR capacities due to insuf-
ficient authority of national IHR focal point; the mis-
conception that implementation of the IHR is the sole
responsibility of ministries of health; dearth of involve-
ment of sectors other than human health (e.g., animal
health sectors); limited investment of national financial
and human resources; high staff turnover; still recover-
ing from devastating effects of recent civil conflict; and
limited international solidarity to support such coun-
tries in developing, strengthening and maintaining core
IHR capacities [20].
Table 1 Ebola death-related total discounted NHGDPLoss by age group (at 2013 prices)
Country NHGDP loss (INT$) by age group
0–14 years 15–44 years = >45 years All ages
Guinea 10,011,713 29,078,934 4,277,754 43,368,401 (27.86 %)
Liberia 12,312,879 37,158,983 4,754,709 54,226,571 (34.84 %)
Mali 150,753 – – 150,753 (0.10 %)
Nigeria – 378,909 – 378,909 (0.24 %)
Sierra Leone 19,975,269 36,538,652 1,024,689 57,538,610 (36.96 %)
Total 42,450,614 (27.27 %) 103,155,478 (66.27 %) 10,057,152 (6.46 %) 155,663,244 (100 %)
Fig. 2 Percentage distribution of NHGDPLoss in the five West African countries
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The three most affected countries (Guinea, Liberia and
Sierra Leone) have developed health sector recovery
plans, which, if fully funded and efficiently implemented,
are expected to result in resilient health systems charac-
terised by safe and healthy work settings; increased pri-
mary healthcare facility coverage in all areas; increased
skilled workforce; increased community trust, ownership
and access to essential health services; strengthened
epidemic preparedness, surveillance and response com-
pliant with international health regulations; improved
health system governance; efficient intersectoral action
on social determinants of health; and effective cross-
border collaboration [21–23]. Following the July 2015
United Nations organized International Ebola Recovery
Conference, the international community pledged more
than five billion dollars to Guinea, Liberia and Sierra
Leone to implement their recovery plans [24]. Therefore,
there is optimism that if all the pledges are honoured
the three countries would be able implement their re-
covery plans, and hence, build resilient health systems and
IHR core capacities at all public health response levels.
Limitations of the study
The present study had five main limitations. First, it
does not include costs of alternative interventions
that could prevent EVD-related morbidity and mortal-
ity and, thus, it cannot inform public health priority
settings [25, 26]. Therefore, the purpose of this study
was just to raise awareness among the public and
policy-makers in the relevant ministries of health and
finance about the negative impact of deaths associated
with EVD on NHGDP.
Second, our study did not include direct healthcare
costs such as those related to vaccines, drugs, tests, sup-
plies, hospital, building and equipping EVD treatment
centres, personnel involved in contact tracing and caring
for patients, diagnostic and waste disposal equipment
and physical facilities; direct non-healthcare costs of
treatment such as transport; patients’ time costs; costs of
volunteers’ time, or cost of family or friends accompany-
ing patients to healthcare centres; loss in productivity due
to morbidity before premature death; and intangible costs
such as pain and grief due to premature loss of loved ones
[27]. Thus, at best, this study is a partial cost-of-illness
study.
Third, GDP calculations omit housework, including
rearing children, preparing meals, caring for sick house-
hold members, and nursing and/or giving other assistance
to the elderly. According to Becker, this undervalues the
contribution of women, who are primarily responsible for
household duties [28]. In addition, use of NHGDPPC,
which is an average, disregards income distribution within
a country and does not account for eternality (secondary
negative effects) costs of production, e.g., environmental
pollution from production processes.
Fourth, because EVD [29] put a massive strain on
health systems, in terms of both direct (e.g., illness and
death of the health workforce, abandonment of health
facilities due to fear of contagion) and indirect effects,
health systems were unable to properly accommodate
patients suffering from other diseases (e.g., measles,
HIV/AIDS, malaria, tuberculosis, maternal complica-
tions). The present study does not take into account
the increase in morbidity and mortality from these
other causes.
Lastly, the present study excludes the negative impact
of EVD-related fear, panic and morbidity on exports,
agriculture, industry (especially mining and tourism) and
education due to closure of schools.
Conclusions
In spite of alluded limitations, the estimates of human
and economic losses reported in this paper, in addition
to those projected by the World Bank, show that EVD
imposes a significant economic burden on the affected
West African countries. That heavy burden, coupled
with human rights and global security concerns, under-
scores the urgent need for increased domestic and ex-
ternal investments to, in solidarity, support Guinea,
Liberia and Sierra Leone (and other vulnerable African
countries) to:




loss in Int$ (B)
Productivity loss per
person in Int$, (C = B / A)
Guinea 11,745,000 43,368,401 3.69
Liberia 4,294,000 54,226,571 12.63
Mali 15,302,000 150,753 0.01




Total 211,048,000 155,663,244 0.74
Table 2 Average NHGDPLoss per death associated with EVD
(Int$)
Country Total number of
EVD deaths (A)
Total productivity
loss in Int$, PPP (B)
Productivity loss per
death associated with
EVD in Int$, (C = B/A)
Guinea 2482 43,368,401 17,473
Liberia 4806 54,226,571 11,283
Mali 6 150,753 25,126




Total 11,234 155,663,244 13,856a
aThe overall average loss is NHGDPLoss (B) divided total deaths (A),
i.e., $155,663,244/11234 = $13,856.44
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 Develop resilient local and national health systems [16];
 Develop core IHR capacities [19];
 Strengthen the interface between health and all
other relevant sectors, including animal health,
education, food, housing, transport, travel, tourism,
water, sanitation, etc. [30];
 Strengthen the governance of national system of
research for health to ensure production pertinent
evidence and its use in the process of developing
various systemic capacities [31]; and
 Strengthen political leadership and governance
capacities at local, intermediate and national levels
[32, 33].
In addition, there is urgent need for further research
to determine:
 Economic feasibility of various systems of ensuring
universal health coverage.
 Feasibility of community/village multi-sectoral
development committees (agriculture, education,
health, water and sanitation, transport, security);
community/village health committees; and health
facility management committees (with community
representation).
 Current core IHR capacities, bottlenecks and
economically feasible ways of developing and
sustaining IHR capacities.
 Functionality of community and district health
systems: management structures, managerial
processes, policy to guide health sector reforms at
district level, collaboration with other actors (e.g.,
other services providers); availability and use of
guidelines, standards and norms at health facilities;
supervision and monitoring; medicines management;
referral mechanisms; health management information
system; priority health activities; community
involvement; health and health-related resources
funding and financial management; human resources;
infrastructure, equipment, supplies and logistics.
 Performance of national system of research for
health and actions for improvement.
 Feasible approaches for changing negative
health-related community behaviours, which makes
them vulnerable to infectious diseases such as EVD.
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